Evidence of biochemical and biomagnetic interactions in Alzheimer's disease: An MEG and MR spectroscopy study

Dementia and Geriatric Cognitive Disorders

Volumn 20, Issue 2-3, 2005, Pages 145-152

  Maestu F ^a   Garcia Segura J ^a,b   Ortiz, T ^a   Montoya, J ^b   Fernandez A ^a   Gil Gregorio, P ^c   Campo, P ^a   Fernandez S ^a   Viano J ^b   Portera, A ^d  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Hospital Ntra Sra del Prado   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d Hospital de Madrid   (Spain)

Author keywords

Alzheimer's disease; Magnetic resonance spectroscopy; Magnetoencephalography; Memory

Indexed keywords

CREATINE KINASE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD CHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; EVIDENCE BASED MEDICINE; HUMAN; MAGNETOENCEPHALOGRAPHY; MENTAL DISEASE; MENTAL TASK; MINI MENTAL STATE EXAMINATION; NEUROCHEMISTRY; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WORKING MEMORY;

AGED; ALZHEIMER DISEASE; ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; CREATINE; FEMALE; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETOENCEPHALOGRAPHY; MALE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE;

EID: 23944438658     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087062     Document Type: Article

References (44)

1. De Carli C, Murphy DGM, McIntosh AR, Teichberg D, Schapiro MB, Horwitz B: Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Res 1995;57:119-130.
2. Laakso MP, Soininen H, Partanen K: Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions. J Neural Transm Park Dis Dement Sect 1995;9:73-86.
3. Kidron D, Black SE, Stanchev P, et al: Quantitative MR volumetry in Alzheimer's disease. Topographic markers and the effect of sex and education. Neurology 1997;49:1504-1512.
4. Juottonen K, Laakso MP, Partanen K, Soininen H: Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. AJNR Am J Neuroradiol 1999;20:139-144.
5. Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F: Use of structural Magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 2000;47:430-439.
6. Jack CR Jr, Petersen RC, Xu YC, et al: Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-794.
7. Rapoport SI: Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: A critical review. Cerebrovasc Brain Metab Rev 1991;3:297-335.
8. Dierks T, Jelic V, Pascual-Marqui RD, et al: Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer disease. Clin Neurophysiol 2000;111:1817-1824.
9. Minoshima S, Giordani B, Berent S, et al: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
10. Jagust WJ, Eberling JL, Reed BR, Mathis CA, Budinger TF: Clinical studies of cerebral blood flow in Alzheimer's disease. Ann NY Acad Sci 1997;826:254-262.
11. Jagust WJ, Haan MN, Reed BR, Eberling JL: Brain perfusion imaging predicts survival in Alzheimer's disease. Neurology 1998;51:1009-1013.
12. 99mTc-HM-PAO SPECT in the investigation of dementia? J Neurol Neurosurg Psychiatry 1998;64:306-313.
13. Yamaguchi S, Meguro K, Itoh M, et al: Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. J Neurol Neurosurg Psychiatry 1997;62:596-600.
14. Johnson KA, Jones K, Holman BL, et al: Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563-1571.
15. Danielsen ER, Ross B: Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York, Dekker Inc. 1999.
16. Shonk TK, Moats RA, Gifford P, Michaelis T, Mandigo JC, Izumi J, Ross BD: Probable Alzheimer disease: Diagnosis with proton MR spectroscopy. Radiology 1995;195:65-72.
17. 1H MRS study. Neurology 2000;55:210-217.
18. Fernandez A, Maestu F, Amo C, et al: Focal temporo-parietal slow activity in Alzheimer's disease revealed by magnetoencephalography. Biol Psychiatry 2002;52:764-770.
19. Fernandez A, Arrazola J, Maestu F, et al: Correlations of hippocampal atrophy and focal low-frequency magnetic activity in Alzheimer disease: Volumetric MR imaging-magnetoencephalographic study. AJNR Am J Neuroradiol 2003;24:481-487.
20. Maestú F, Fernandez A, Simos PG, et al: Spatio-temporal patterns of brain magnetic activity during a memory task in Alzheimer's disease. Neuroreport 2001;12:3917-3922.
21. Maestú F, Arrazola J, Fernandez A, et al: Do cognitive patterns of brain magnetic activity correlate with hippocampal atrophy in Alzheimer's disease? J Neurol Neurosurg Psychiatry 2003;74:208-212.
22. Asahina M, Yoshiyama Y, Hattori T: Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain. Clin Neuropathol 2001;20:60-63.
23. Lobo A, Ezquerra J, Gomez Burgada F, et al: Cognitive mini-test (a simple practical test to detect intellectual changes in medical patients). Actas Luso Esp Neurol Psiquiatr Cienc Afines 1979;7:189-202.
24. Simos PG, Breier JI, Zouridakis G, Papanicolaou AC: Identification of language-specific brain activity using magnetoencephalography. J Clin Exp Neuropsychol 1998;20:706-722.
25. Maestú F, Ortiz T, Fernandez A, et al: Spanish language mapping using MEG: A validation study. Neuroimage 2002;17:1579-1586.
26. Maestú F, Simos PG, Campo P, et al: Modulation of brain magnetic activity by different verbal learning strategies. Neuroimage 2003;20:1110-1121.
27. Breier JI, Simos PG, Zouridakis G, Papanicolaou AC: Temporal course of regional brain activation associated with phonological decoding. J Clin Exp Neuropsychol 1999;21:465-476.
28. Breier JI, Simos PG, Wheless JW, et al: Language dominance in children as determined by magnetic source imaging and the intracarotid amobarbital procedure: A comparison. J Child Neurol 2001;16:124-130.
29. Webb PG, Sailasuta N, Kohler SJ, et al: Automated single-voxel proton MRS: Technical development and multisite verification. Magn Reson Med 1994;31:365-373.
30. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
31. Seeger U, Klose U, Mader I, et al: Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magn Reson Med 2003;49:19-28.
32. Ernst T, Kreis R, Ross BD: Absolute quantitation of water and metabolites in human brain. 1. Compartments and water. Magn Reson Med 1993;102:1-8.
33. Kreis R, Ernst T, Ross BD: Absolute quantitation of water and metabolites in human brain. 2. Metabolite concentrations. Magn Reson Med 1993;102:9-19.
34. 1H MRS study. Am J Psychiatry 1999;156:1879-1886.
35. Glanville NT, Byers DM, Cook HW, Spence MW, Palmer FB: Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim Biophys Acta 1989;1004:169-179.
36. Urenjak J, Williams SR, Gadian DG, Noble M: Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989.
37. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO: In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Arch Gen Psychiatry 1999;56:185-192.
38. Adalsteinsson E, Sullivan EV, Kleinhans N, Spielman DM, Pfefferbaum A: Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet 2000;355:1696-1697.
39. 1H MRS study of probable Alzheimer's disease and normal aging: Implications for longitudinal monitoring of dementia progression. Magn Reson Imaging 1999;17:291-299.
40. deToledo-Morrell L, Evers S, Hoeppner TJ, et al: A 'stress' test for memory dysfunction. Electrophysiologic manifestations of early Alzheimer's disease. Arch Neurol 1991;48:605-609.
41. Baddeley A: The episodic buffer: A new component of working memory? Trends Cogn Sci 2000;4:417-423.
42. Belleville S, Peretz I, Malenfant D: Examination of the working memory components in normal aging and in dementia of the Alzheimer type. Neuropsychologia 1996;34:195-207.
43. Thompson PM, Mega MS, Woods RP, et al: Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex 2001;11:1-16.
44. Golebiowski M, Barcikowska M, Pfeffer A: Magnetic resonance imaging-based hippocampal volumetry in patients with dementia of the Alzheimer type. Dement Geriatr Cogn Disord 1999;10:284-288.